DNAL1 activators are chemical compounds that enhance the function of DNAL1 through direct or indirect interaction with the protein and the pathways or cellular processes it is involved in. Among the identified DNAL1 activators are ATP, Ciliobrevin D, Taxol, Vinblastine, Nocodazole, STLC, and GSK-923295. The activation of DNAL1 by ATP is direct, as ATP binding and hydrolysis power dynein's movement along microtubules. ATP is the primary energy currency of the cell and DNAL1, being a component of the dynein motor complex, relies heavily on ATP for its function. Therest of the chemicals primarily exert their effects indirectly by interacting with the pathways and processes that DNAL1 is involved in. For instance, Ciliobrevin D is an inhibitor of dynein ATPase activity. By inhibiting this activity, this compound increases the availability of ATP for DNAL1 to utilize for dynein motor function, thereby enhancing DNAL1 activity.
Taxol, on the other hand, stabilizes microtubules and prevents their depolymerization, providing a stable path for dynein movement and thus enhancing the function of DNAL1. Other compounds such as Vinblastine disrupt microtubules, thereby enhancing DNAL1 activity by releasing it from microtubule-bound complexes. STLC and GSK-923295 are inhibitors of kinesin motor proteins that compete with dynein for microtubule tracks. By inhibiting these proteins, they reduce competition for microtubule tracks, thereby enhancing the function of DNAL1.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Adenosine 5′-Triphosphate, disodium salt | 987-65-5 | sc-202040 sc-202040A | 1 g 5 g | $39.00 $75.00 | 9 | |
ATP, the primary energy currency of the cell, can enhance DNAL1 function. DNAL1 is a component of the dynein motor complex which relies on ATP hydrolysis for its motor function. ATP binding and hydrolysis directly power dynein’s movement along microtubules. | ||||||
Ciliobrevin D | 1370554-01-0 | sc-507482 | 10 mg | $413.00 | ||
Ciliobrevin D is a dynein inhibitor that specifically inhibits dynein ATPase activity. In the presence of Ciliobrevin D, dynein, and by extension, DNAL1, could be released from inhibitory complexes, leading to enhanced DNAL1 activity. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Taxol stabilizes microtubules and prevents their depolymerization. As DNAL1 is part of the dynein complex that moves along microtubules, the stabilization of these structures can enhance the function of DNAL1 by providing a stable path for dynein movement. | ||||||
Vinblastine Sulfate | 143-67-9 | sc-201447 sc-201447A sc-201447B sc-201447C | 10 mg 50 mg 100 mg 1 g | $109.00 $412.00 $561.00 $2244.00 | 9 | |
Vinblastine is a vinca alkaloid that inhibits microtubule formation. This action can indirectly enhance DNAL1 activity by releasing it from microtubule-bound complexes, allowing DNAL1 to participate in other cellular processes. | ||||||
S-Trityl-L-cysteine | 2799-07-7 | sc-202799 sc-202799A | 1 g 5 g | $32.00 $66.00 | 6 | |
STLC is a specific inhibitor of Eg5, a kinesin motor protein. By inhibiting Eg5, STLC can enhance DNAL1 function by reducing competition for microtubule tracks. | ||||||
GSK 923295 | 1088965-37-0 | sc-490136 | 5 mg | $290.00 | ||
GSK-923295 is a specific inhibitor of the kinesin CENP-E. By inhibiting CENP-E, GSK-923295 can enhance the function of DNAL1 by reducing competition for microtubule tracks. | ||||||